vs

Side-by-side financial comparison of Drilling Tools International Corp (DTI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $38.5M, roughly 1.5× Drilling Tools International Corp). Drilling Tools International Corp runs the higher net margin — 3.2% vs -83.0%, a 86.1% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -3.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 2.1%).

Drilling Tools International Corp is a leading provider of specialized drilling tools, rental equipment, and related support services for the global oil and gas exploration and production sector. It primarily serves onshore and offshore drilling operators, oilfield service companies, and energy exploration firms across North America and key international energy markets, delivering durable, high-performance solutions that boost drilling efficiency and operational safety.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

DTI vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.5× larger
RYTM
$57.3M
$38.5M
DTI
Growing faster (revenue YoY)
RYTM
RYTM
+40.2% gap
RYTM
36.9%
-3.4%
DTI
Higher net margin
DTI
DTI
86.1% more per $
DTI
3.2%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
2.1%
DTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DTI
DTI
RYTM
RYTM
Revenue
$38.5M
$57.3M
Net Profit
$1.2M
$-47.5M
Gross Margin
91.6%
Operating Margin
2.9%
-82.2%
Net Margin
3.2%
-83.0%
Revenue YoY
-3.4%
36.9%
Net Profit YoY
190.6%
-9.6%
EPS (diluted)
$0.04
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTI
DTI
RYTM
RYTM
Q4 25
$38.5M
$57.3M
Q3 25
$38.8M
$51.3M
Q2 25
$39.4M
$48.5M
Q1 25
$42.9M
$32.7M
Q4 24
$39.8M
$41.8M
Q3 24
$40.1M
$33.3M
Q2 24
$37.5M
$29.1M
Q1 24
$37.0M
$26.0M
Net Profit
DTI
DTI
RYTM
RYTM
Q4 25
$1.2M
$-47.5M
Q3 25
$-903.0K
$-52.9M
Q2 25
$-2.4M
$-46.6M
Q1 25
$-1.7M
$-49.5M
Q4 24
$-1.3M
$-43.3M
Q3 24
$867.0K
$-43.6M
Q2 24
$365.0K
$-32.3M
Q1 24
$3.1M
$-141.4M
Gross Margin
DTI
DTI
RYTM
RYTM
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
Operating Margin
DTI
DTI
RYTM
RYTM
Q4 25
2.9%
-82.2%
Q3 25
-1.2%
-102.6%
Q2 25
-4.2%
-93.4%
Q1 25
7.7%
-143.7%
Q4 24
4.5%
-98.6%
Q3 24
10.6%
-132.0%
Q2 24
6.0%
-139.2%
Q1 24
13.9%
-538.7%
Net Margin
DTI
DTI
RYTM
RYTM
Q4 25
3.2%
-83.0%
Q3 25
-2.3%
-103.1%
Q2 25
-6.1%
-96.1%
Q1 25
-3.9%
-151.4%
Q4 24
-3.4%
-103.6%
Q3 24
2.2%
-131.2%
Q2 24
1.0%
-110.9%
Q1 24
8.5%
-544.4%
EPS (diluted)
DTI
DTI
RYTM
RYTM
Q4 25
$0.04
$-0.73
Q3 25
$-0.03
$-0.82
Q2 25
$-0.07
$-0.75
Q1 25
$-0.05
$-0.81
Q4 24
$-0.06
$-0.71
Q3 24
$0.03
$-0.73
Q2 24
$0.01
$-0.55
Q1 24
$0.11
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTI
DTI
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$3.6M
$388.9M
Total DebtLower is stronger
$45.8M
Stockholders' EquityBook value
$122.9M
$139.1M
Total Assets
$222.2M
$480.2M
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTI
DTI
RYTM
RYTM
Q4 25
$3.6M
$388.9M
Q3 25
$4.4M
$416.1M
Q2 25
$1.1M
$291.0M
Q1 25
$2.8M
$314.5M
Q4 24
$6.2M
$320.6M
Q3 24
$12.0M
$298.4M
Q2 24
$6.8M
$319.1M
Q1 24
$14.1M
$201.2M
Total Debt
DTI
DTI
RYTM
RYTM
Q4 25
$45.8M
Q3 25
$51.3M
Q2 25
$56.9M
Q1 25
$54.9M
Q4 24
$53.8M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DTI
DTI
RYTM
RYTM
Q4 25
$122.9M
$139.1M
Q3 25
$121.1M
$148.8M
Q2 25
$122.5M
$-11.9M
Q1 25
$122.7M
$18.9M
Q4 24
$120.0M
$21.7M
Q3 24
$-123.2M
$11.2M
Q2 24
$92.8M
$39.3M
Q1 24
$91.5M
$61.6M
Total Assets
DTI
DTI
RYTM
RYTM
Q4 25
$222.2M
$480.2M
Q3 25
$227.4M
$506.9M
Q2 25
$230.3M
$372.7M
Q1 25
$233.2M
$386.7M
Q4 24
$222.4M
$392.3M
Q3 24
$218.8M
$363.6M
Q2 24
$166.9M
$381.8M
Q1 24
$167.0M
$258.7M
Debt / Equity
DTI
DTI
RYTM
RYTM
Q4 25
0.37×
Q3 25
0.42×
Q2 25
0.46×
Q1 25
0.45×
Q4 24
0.45×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTI
DTI
RYTM
RYTM
Operating Cash FlowLast quarter
$5.3M
$-25.4M
Free Cash FlowOCF − Capex
$1.3M
FCF MarginFCF / Revenue
3.4%
Capex IntensityCapex / Revenue
10.4%
Cash ConversionOCF / Net Profit
4.38×
TTM Free Cash FlowTrailing 4 quarters
$-224.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTI
DTI
RYTM
RYTM
Q4 25
$5.3M
$-25.4M
Q3 25
$10.0M
$-26.6M
Q2 25
$2.2M
$-23.3M
Q1 25
$2.4M
$-40.4M
Q4 24
$-3.7M
$-18.8M
Q3 24
$5.3M
$-25.2M
Q2 24
$1.1M
$-29.1M
Q1 24
$3.3M
$-40.7M
Free Cash Flow
DTI
DTI
RYTM
RYTM
Q4 25
$1.3M
Q3 25
$6.4M
Q2 25
$-5.4M
Q1 25
$-2.6M
Q4 24
$-6.9M
Q3 24
$2.0M
Q2 24
$-9.0M
Q1 24
$-2.9M
FCF Margin
DTI
DTI
RYTM
RYTM
Q4 25
3.4%
Q3 25
16.5%
Q2 25
-13.6%
Q1 25
-6.1%
Q4 24
-17.3%
Q3 24
4.9%
Q2 24
-24.0%
Q1 24
-7.9%
Capex Intensity
DTI
DTI
RYTM
RYTM
Q4 25
10.4%
Q3 25
9.1%
Q2 25
19.2%
Q1 25
11.8%
Q4 24
8.1%
Q3 24
8.4%
Q2 24
26.9%
Q1 24
16.8%
Cash Conversion
DTI
DTI
RYTM
RYTM
Q4 25
4.38×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
6.15×
Q2 24
2.96×
Q1 24
1.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTI
DTI

Tool Rental$30.4M79%
Products$8.1M21%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons